Blog

Teva goes for jugular on certificate of correction issue.

Court finds Meda Pharmaceuticals’ delay asserting certificate of correction precludes adding the corrected claim to the lawsuit.

Hatch Waxman Litigation

June 20, 2017

Pennsaid® patent illustrates importance and strength of exception excipient rules.

Horizon’s formulation patent for Pennsaid® survives validity challenge and prevents generic entry in spite of narrow breadth.

Exception Excipient Rules

June 05, 2017